[3] Initial treatment of pernicious anemia typically consists of 1,000 mcg intramuscularly daily for one week, then weekly for four weeks, transitioning to 1,000 mcg monthly for life
This restoration of metabolic cofactor availability enables enhanced function of NAD+-dependent enzymes including sirtuins, poly(ADP-ribose) polymerases, and various deacetylases that regulate cellular metabolism, stress responses, and aging processes
Cofactor-dependent enzymatic activity related to lipid transport and processing
Common signs are: Fatigue and weakness Neurological changes, such as numbness or tingling in extremities Megaloblastic anemia, characterized by large, abnormal red blood cells We urge quick medical help if these signs dont go away
Under the Human Medicines Regulations 2012, selling or supplying either compound with therapeutic claims in the UK without a Marketing Authorisation is illegal